GSK's Walmsley gets £2.5m pay rise after strong 2019

There can’t be many people in the UK who enjoyed a £2.5 million pay rise this year – but that’s what GlaxoSmithKline boss Emma Walmsley got after a strong year for sales.

J&J's Apple Watch-based atrial fibrillation study recruits p...

Apple and Johnson & Johnson have begun enrolling patients in a study that will investigate whether the Apple Watches could be used to detect early signs of atrial fibrillation (AFib).

Jury trial levies $750m damages on J&J over talc and cancer

NICE rejects J&J’s Spravato for treatment-resistant depressi...

Washington State is latest to sue Janssen over opioid market...

Washington State has become the latest to sue Johnson & Johnson over the way it marketed opioid painkillers, according to press reports.

FDA knocks back ViiV, J&J’s long-acting HIV regimen